LRG1 and progressive supranuclear palsy: The level of LRG1 in the cerebrospinal fluid of patients with Parkinson's disease combined with dementia (PDD) and progressive supranuclear palsy (PSP) is significantly increased, while the deposition of LRG1 in the cerebral cortex increases with age.